Pipeline

We have established a product pipeline focused on innovative drugs for brain diseases.

Fourth-generation MAO-B inhibitor New chemical entity

Parkinson's disease (PD) is a prevalent neurodegenerative disorder, which cannot be completely cured by current medications. Abnormal metabolism of dopamine

Positive allosteric modulator of GABAA receptors New chemical entity

Postpartum depression, refractory epilepsy

IDO1/TDO dual inhibitor New chemical entity

Inflammatory depression

GABAB receptor agonist Old drugs for new uses

Amyotrophic lateral sclerosis, spastic pain

About Us

Devoted to the research and development of innovative drugs in the field of major brain diseases

Suzhou Brainlight Biomedical Technology Co., Ltd (abbreviated as “BLT medicine”) was officially established on April 30, 2025, dedicated to the research and development of innovative drugs in the field of major brain diseases. We focus on central nervous system (CNS) diseases such as Parkinson's disease, depression, epilepsy, migraine, stroke, and amyotrophic lateral sclerosis, as well as their complex comorbidities. We aim to provide safe, effective and accessible treatment solutions for patients worldwide.

Our mission and vision

wisdom as the light, to illuminate lives

Our values

Great achievements come from ambition;
Grate accomplishments come from diligence.

Technical Services

anchoring the key target, acting in concert through multiple pharmacological mechanism

Drug Design and Synthesis

  • Preparation of positive drugs and standard samples
  • Design and synthesis of F18-labeled, fluorescent-labeled, biotin-labeled probes
  • Design and synthesis of PROTACs
  • Synthesis of raw materials, intermediates, impurities, and metabolites
  • Synthesis of tritiated drugs
  • Synthesis and resolution of chiral drugs
  • Enzymatic synthesis of chiral intermediates for pharmaceuticals
  • High-quality synthesis ranging from milligram to hundred-kilogram levels…

Process Development of the Synthetic Route to these

  • Rimegepant (BMS-927711)
  • Zavegepant (AJ919)
  • Ubrogepant (MK-1602)
  • Gefapixant(AF-219, MK-7264)
  • Firsocostat (ND-630)
  • Hypoxystat
  • Zerencotrep (Pico145, HC-608)
  • D-Luciferin potassium salt
  • Others:84-B10, CPAG-1, W146, SP141, HC-070, M110。